Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

p53 deletion as a genetic marker in urothelial tumor by fluorescence in situ hybridization.

Cancer research - 1 Dec 1994

Matsuyama H, Pan Y, Mahdy E A, Malmström P U, Hedrum A, Uhlen M, Busch C, Hirano T, Auer G, Tribukait B

Abstract excerpt

In order to investigate the significance of p53 deletion, 42 specimens of transitional cell carcinoma were analyzed by interphase cytogenetics with a fluorescence in situ hybridization technique and compared with clinicopathological and cytochemical parameters. In total, 27 (64%) and 16 (38%) specimens demonstrated p53 deletion and overexpression, respectively. The p53 deletion was significantly correlated with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to Gene Deletion

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genes, p53

Share to Genetic Markers

Share to In Situ Hybridization, Fluorescence

Share to Mutation

Share to Urinary Bladder Neoplasms

Source

Identifiers

PMID: 7954445

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

p53 deletion as a genetic marker in urothelial tumor by fluorescence in situ hybridization.PMID 7954445Read ↗

Physical deletion of the p53 gene in bladder cancer. Detection by fluorescence in situ hybridization.Semantic proximity Read ↗

Abnormalities in p53 and DNA content in transitional cell carcinoma of the bladder.Semantic proximity Read ↗

Evaluation of overexpression of p53 tumor suppressor protein in superficial and invasive transitional cell bladder cancer: comparison with DNA ploidy.Semantic proximity Read ↗

Study of mutated p53 protein by immunohistochemistry in urothelial neoplasm of urinary bladder.Semantic proximity Read ↗

p53 and human papillomavirus DNA in renal pelvic and ureteral carcinoma including dysplastic lesions.Semantic proximity Read ↗

[p53 in urogenital tumors:analysis of expression and mutation].Semantic proximity Read ↗

Analysis of p53 tumor suppressor gene mutations and human papillomavirus infection in human bladder cancers.Semantic proximity Read ↗

Inactivation of tumor suppressor genes and deregulation of the c-myc gene in urothelial cancer cell lines.Semantic proximity Read ↗

p53 protein and Ki-67 overexpression in urothelial dysplasia of bladder.Semantic proximity Read ↗

[Use of fluorescent in situ hybridization in the cytogenetic diagnosis of urinary bladder urothelial carcinoma].Semantic proximity Read ↗

Numeric aberration of chromosome 17 is strongly correlated with p53 overexpression, tumor proliferation and histopathology in human bladder cancer.Semantic proximity Read ↗

[Proliferative activity and p53 expression in transitional cell carcinoma of the urinary bladder].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.